- Innovation
IRA Drug Price Negotiation Impact on Cardiovascular Drugs

A new Avalere white paper raises important considerations on potential added lifecycle pressures for sponsors of cardiovascular disease products.
A new Avalere white paper raises important considerations on potential added lifecycle pressures for sponsors of cardiovascular disease products.